
2 Things Investors Need to Know About Internet Computer in 2026
It is hard to see how Internet Computer can rebuild investor confidence.

It is hard to see how Internet Computer can rebuild investor confidence.

Gov. Gordon signs emergency rules to administer property tax exemption
DURHAM, N.C., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today reported its financial results for the third quarter ended December 31, 2025.
NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Marex Group plc ((‘Marex' or the ‘Group', NASDAQ:MRX), the diversified global financial services platform, today announces that it has agreed to acquire European equity derivatives market maker Webb Traders to enhance its market making capabilities.Webb Traders has offices in Amsterdam and Paris and specialises in single stock options market making for European and US mid and large cap equities. The acquisition will bring to Marex a strong, technology led team of market makers, quants and developers, as well as electronic trading capabilities. Webb Traders' trading and risk management philosophy is fully aligned with Marex's approach.The acquisition is expected to further enhance Marex's established Equity Linked Structured Products platform allowing the Group to internalise hedging, enhance profit margins and provide better pricing for clients. The deal is subject to regulatory approval and is expected to close in the second or third quarter of 2026. Ian Lowitt, Chief Executive Officer of Marex, commented: "We are excited to welcome the team from Webb Traders to Marex. They have built an incredibly talented team supported by excellent technology, which will enhance our equity derivatives capabilities. They have a prudent approach to risk and have been profitable across a range of market environments, which, combined with the ability to internalise some hedging costs, will be beneficial to Marex."Forward-Looking Statements:This press release contains ...Full story available on Benzinga.com

Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025 Cash of $17.6 Million at December 31, 2025 LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in...

VANCOUVER, BC , Feb. 6, 2026 /PRNewswire/ - Thesis Gold Inc. ("Thesis" or the "Company") (TSXV:TAU) (WKN: A3EP87) (OTCQX:THSGF) is pleased to announce the appointment of Ms. Coille van Alphen to its Board of Directors, effective immediately. Ms. van Alphen is a seasoned mining investment professional with over 15 years of experience across public equities, capital markets, and strategic investing. She currently serves as a Mining & Metals Portfolio Manager at Equinox Partners, a value-oriented investment firm with a long-term focus on resource equities and the largest institutional shareholder of Thesis. Previously, Ms. van Alphen held senior investment roles at the Canada Pension Plan Investment Board and Canaccord Genuity, where she focused on global mining and metals investments. Her appointment further strengthens the Company's Board as Thesis transitions from advanced exploration into ...Full story available on Benzinga.com

A return to top-tier form.

Jeweller Pandora has said it will switch from using silver in some of its ranges to platinum following a dramatic increase in prices. Silver has seen its price more than double over the past year, with other precious metal prices also surging. Pandora’s chief executive said its aim was not to make all jewellery platinum-plated, [...]
DURHAM, N.C., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Priovant Therapeutics today announced positive results from the Phase 2 BEACON study evaluating brepocitinib in cutaneous sarcoidosis (CS). CS is a highly morbid, chronic, and disfiguring condition with no approved therapies, and the BEACON study is the first ever industry-sponsored placebo-controlled trial in the indication to read out positively.
BASEL, Switzerland and LONDON and NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced positive Phase 2 results for brepocitinib in cutaneous sarcoidosis (CS) and reported its financial results for the third quarter ended December 31, 2025.

Disenfranchisement: The Company is trying to intimidate shareholders by falsely suggesting lawful dissident proxy votes may not be counted or will be counted at their discretion.Entrenchment over accountability: Rather than defend its record, the Company is attempting to cling to power by undermining shareholder choice and spending more of shareholder cash on flimsy legal strategy and using legal tactics to deny votes against them.Misleading tactics: Casting doubt on dissident proxy cards is a deliberate effort to confuse investors and suppress independent voting.Threat to corporate democracy: Free and fair elections require that all valid shareholder votes be counted—no matter who they support.Shareholders should stand up for their rights and vote only the GOLD proxy or GOLD VIF for much needed change at Labrador. Concerned Shareholders will defend that legal right.VANCOUVER, BC, Feb. 6, 2026 /CNW/ - Coloured Ties Capital Inc. (TSXV:TIE) (OTC:APEOF) (FSE: 97A0) ("Coloured Ties"), one of the largest shareholders of Labrador Gold Corp. (TSX.V: LAB) (OTCQB:NKOSF) (FSE: 2N6) ("Labrador" or the "Company"), together with Kal Malhi and Rauni Malhi (the "Concerned Shareholders", "us" or "we"), strongly condemn recent statements by Labrador suggesting that shareholder votes cast on the GOLD proxy "may" not be counted, calling the maneuver a blatant attempt to intimidate shareholders and undermine the integrity of the corporate governance process. The threat is clear; if they lose, they will refuse to count votes against them. This is a flimsy technical argument that we do not believe is valid, nor is it ethical or acceptable corporate governance. Should the Company deny shareholder votes as threatened, we intend to take all action necessary to enforce the rights of all shareholders and uphold shareholder democracy.By raising spurious and misleading claims about the validity of the GOLD proxy, Labrador is attempting to sow confusion among investors and suppress lawful shareholder participation at a critical moment for the Company. These tactics are not about compliance or clarity — they are about entrenchment.Every shareholder has a fundamental right to have their vote counted, ...Full story available on Benzinga.com
